Beijing Strong Biotechnologies,Inc.

Equities

300406

CNE100001Y26

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
17.75 ^CNY	+1.66%		+3.98%	-7.07%

Apr. 01	Beijing Strong Biotechnologies,Inc. Proposes Final Cash Dividend for 2023	CI
Apr. 01	Tranche Update on Beijing Strong Biotechnologies,Inc.'s Equity Buyback Plan announced on July 21, 2023.	CI

Tranche Update on Beijing Strong Biotechnologies, Inc.'s Equity Buyback Plan announced on March 7, 2022.

December 07, 2022 at 03:20 am EST

From October 1, 2022 to December 7, 2022, the company has repurchased 1,148,800 shares, representing 0.2% for CNY 20.01 million. With this, the company has completed the repurchase of 2,867,000 shares, representing 0.49% for CNY 50 million under the buyback announced on March 7, 2022.

Latest news about Beijing Strong Biotechnologies,Inc.

Beijing Strong Biotechnologies,Inc. Proposes Final Cash Dividend for 2023	Apr. 01	CI
Tranche Update on Beijing Strong Biotechnologies,Inc.'s Equity Buyback Plan announced on July 21, 2023.	Apr. 01	CI
Beijing Strong Biotechnologies,Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
Tranche Update on Beijing Strong Biotechnologies,Inc.'s Equity Buyback Plan announced on July 21, 2023.	Jan. 03	CI
Tianfu Energy Chairman Proposes Buyback of Up to 30 Million Yuan Shares	Dec. 13	MT
Neo-Neon CFO Steps Down; Successor Named	Nov. 20	MT
ASIA COPPER WEEK-China to expand imports of scrap copper -industry association	Nov. 15	RE
Beijing Strong Biotechnologies,Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24	CI
Tranche Update on Beijing Strong Biotechnologies,Inc.'s Equity Buyback Plan announced on July 21, 2023.	23-10-11	CI
Beijing Strong Biotechnologies,Inc. Approves Executive Appointments	23-09-25	CI
Beijing Strong Biotechnologies, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-09	CI
Beijing Strong Biotechnologies, Inc. announces an Equity Buyback for CNY 80 million worth of its shares.	23-07-21	CI
Beijing Strong Biotechnologies, Inc. authorizes a Buyback Plan.	23-07-20	CI
Beijing Strong Biotechnologies, Inc. Announces Dividend on Share A for 2022, Payable on May 22, 2023	23-05-16	CI
Beijing Strong Biotechnologies, Inc. Approves Cash Dividend for 2022	23-05-12	CI
Beijing Strong Biotechnologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Beijing Strong Biotechnologies, Inc. Proposes Final Cash Dividend for the Year 2022	23-04-20	CI
Beijing Strong Biotechnologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-19	CI
Tranche Update on Beijing Strong Biotechnologies, Inc.'s Equity Buyback Plan announced on March 7, 2022.	22-12-07	CI
Beijing Strong Biotechnologies, Inc.'s Equity Buyback announced on May 7, 2022, has expired with 2,867,000 shares, representing 0.49% for ¥50 million.	22-12-06	CI
Beijing Strong Biotechnologies, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Factbox-China's new political elites and their connection to Xi	22-10-24	RE
'Alarm Bells' Ring as China Shuffles Economic Leaders at Critical Time	22-10-10	MT
Tranche Update on Beijing Strong Biotechnologies, Inc.'s Equity Buyback Plan announced on March 7, 2022.	22-10-09	CI
Beijing Strong Biotechnologies, Inc. signed an Equity Transfer Agreement to acquire an additional 4.45% stake in Fuzhou Maixin Biotech. Co., Ltd. from Xinyu Yuanlang Management Consulting Partnership (Limited Partnership) for approximately CNY 130 million.	22-08-28	CI

Chart Beijing Strong Biotechnologies,Inc.

Duration

Period

Chart Beijing Strong Biotechnologies,Inc.

More charts

Company Profile

Beijing Strong Biotechnologies Inc. is a China-based company mainly engaged in the research and development, manufacture and sales of in vitro diagnostic reagents. The Companyâs in vitro diagnostic reagents are mainly used in liver, renal, blood fat, glycometabolism and other fields. The Company is also engaged in the manufacture and sales of in vitro diagnostic equipment and the leasing of equipment. The Company operates businesses in domestic and overseas markets.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-04-28 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Beijing Strong Biotechnologies,Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

17.75

Average target price

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
BEIJING STRONG BIOTECHNOLOGIES,INC.	-7.07%	1.41B
BIOMÉRIEUX	+0.89%	12.59B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-10.29%	7.42B
DIASORIN S.P.A.	+1.78%	5.35B
AUTOBIO DIAGNOSTICS CO., LTD.	-1.16%	4.51B
LANTHEUS HOLDINGS, INC.	+5.74%	4.47B
10X GENOMICS, INC.	-50.70%	3.21B
ANDON HEALTH CO., LTD.	+12.21%	2.71B
VITROLIFE AB	-16.13%	1.96B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-11.50%	1.73B

Diagnostic & Testing Substances